W L Hicks1, K Nowels, J Troxel. Show Affiliations » 1. Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract
Entities: Disease
Mesh: See more » Administration, OralAdultAmphotericin B/administration & dosageAmphotericin B/therapeutic useAnti-Bacterial Agents/therapeutic useAntifungal Agents/therapeutic useBlood/microbiologyCeftazidime/therapeutic useEscherichia coli/isolation & purificationHodgkin Disease/complicationsHodgkin Disease/pathologyHumansInjections, IntravenousInsect Bites and StingsMaleMucormycosis/complicationsMucormycosis/diagnosisMucormycosis/drug therapyNeck/physiopathologyNecrosisRifampin/administration & dosageRifampin/therapeutic useTetracycline/therapeutic use
Substances: See more » Anti-Bacterial AgentsAntifungal AgentsAmphotericin BCeftazidimeTetracyclineRifampin
Year: 1995 PMID: 7573749 DOI: 10.1016/0196-0709(95)90155-8
Source DB: PubMed Journal: Am J Otolaryngol ISSN: 0196-0709 Impact factor: 1.808